• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2009年加拿大心血管学会/加拿大成人血脂异常诊断与治疗及心血管疾病预防指南——2009年推荐意见

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

作者信息

Genest Jacques, McPherson Ruth, Frohlich Jiri, Anderson Todd, Campbell Norm, Carpentier André, Couture Patrick, Dufour Robert, Fodor George, Francis Gordon A, Grover Steven, Gupta Milan, Hegele Robert A, Lau David C, Leiter Lawrence, Lewis Gary F, Lonn Eva, Mancini G B John, Ng Dominic, Pearson Glen J, Sniderman Allan, Stone James A, Ur Ehud

机构信息

McGill University Health Centre, Montreal, Canada.

出版信息

Can J Cardiol. 2009 Oct;25(10):567-79. doi: 10.1016/s0828-282x(09)70715-9.

DOI:10.1016/s0828-282x(09)70715-9
PMID:19812802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2782500/
Abstract

The present article represents the 2009 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult.

摘要

本文介绍了加拿大心血管学会2009年版成人血脂异常诊断与治疗及心血管疾病预防指南。

相似文献

1
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.2009年加拿大心血管学会/加拿大成人血脂异常诊断与治疗及心血管疾病预防指南——2009年推荐意见
Can J Cardiol. 2009 Oct;25(10):567-79. doi: 10.1016/s0828-282x(09)70715-9.
2
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.2012 年加拿大心血管学会血脂异常诊断和治疗指南更新：预防成年人心血管疾病。
Can J Cardiol. 2013 Feb;29(2):151-67. doi: 10.1016/j.cjca.2012.11.032.
3
Northern light: a commentary on the 2009 Canadian Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in adults.《北极光：对2009年加拿大成人血脂异常诊断与治疗及心血管疾病预防指南的评论》
Clin Chem. 2010 Apr;56(4):502-4. doi: 10.1373/clinchem.2009.139196. Epub 2010 Feb 25.
4
Simplifying the approach to the management of dyslipidemia.简化血脂异常的管理方法。
JAMA. 2009 Nov 18;302(19):2148-9. doi: 10.1001/jama.2009.1685.
5
The new dyslipidemia guidelines: what is the debate?新的血脂异常指南：争议点是什么？
Can J Cardiol. 2015 May;31(5):605-12. doi: 10.1016/j.cjca.2014.11.007. Epub 2014 Nov 11.
6
Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.西班牙心血管疾病预防跨学科委员会及西班牙心脏病学会关于血脂异常管理的立场声明。欧洲和美国指南之间的差异。
Rev Esp Cardiol (Engl Ed). 2014 Nov;67(11):913-9. doi: 10.1016/j.rec.2014.05.008. Epub 2014 Aug 3.
7
[Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].[西班牙心血管疾病预防跨学科委员会及西班牙心脏病学会关于血脂异常管理的立场声明。欧洲和美国指南的差异]
Semergen. 2015 Apr;41(3):149-57. doi: 10.1016/j.semerg.2014.05.020. Epub 2014 Nov 14.
8
News from ESC congress 2019: New ESC/EAS guidelines for dyslipidaemia management published.2019年欧洲心脏病学会（ESC）大会消息：欧洲心脏病学会/欧洲动脉粥样硬化学会（ESC/EAS）血脂异常管理新指南发布。
Atherosclerosis. 2019 Dec;291:124-126. doi: 10.1016/j.atherosclerosis.2019.09.013. Epub 2019 Oct 5.
9
[To improve cardiovascular health: we are forced for not loosing impulse].为改善心血管健康：我们不能失去动力。 （原英文句子语法有误，正确表达可能是To improve cardiovascular health, we are forced not to lose impulse ）
Clin Investig Arterioscler. 2016 Jan-Feb;28(1):43-6. doi: 10.1016/j.arteri.2015.10.001. Epub 2015 Nov 14.
10
Re: Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.关于：加拿大心血管学会立场声明——血脂异常的诊断与治疗及心血管疾病预防的建议
Can J Cardiol. 2007 May 1;23(6):481-2; author reply 483. doi: 10.1016/s0828-282x(07)70793-6.

引用本文的文献

1
Improving cardiovascular risk stratification: the role of abdominal obesity in predicting MACEs.改善心血管风险分层：腹型肥胖在预测主要不良心血管事件中的作用。
Cardiovasc Diabetol. 2025 Aug 11;24(1):328. doi: 10.1186/s12933-025-02885-4.
2
Emerging Biomarkers and Electrochemical Biosensors for Early Detection of Premature Coronary Artery Disease.用于早期检测冠状动脉疾病的新兴生物标志物和电化学生物传感器
Diagnostics (Basel). 2025 Apr 7;15(7):940. doi: 10.3390/diagnostics15070940.
3
Prevalence and Characteristics of Dyslipidemia in a Hospital in Madagascar.马达加斯加一家医院血脂异常的患病率及特征
Cureus. 2024 Nov 11;16(11):e73424. doi: 10.7759/cureus.73424. eCollection 2024 Nov.
4
Severe bronchiectasis is associated with increased carotid intima-media thickness.严重的支气管扩张症与颈动脉内膜中层厚度增加有关。
BMC Cardiovasc Disord. 2024 Aug 28;24(1):457. doi: 10.1186/s12872-024-04129-x.
5
Knowledge, attitudes, and practices of cardiac rehabilitation among physiotherapists in Morocco.摩洛哥物理治疗师对心脏康复的知识、态度和实践
Glob Cardiol Sci Pract. 2024 Apr 20;2024(3):e202423. doi: 10.21542/gcsp.2024.23.
6
Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian Randomization.探讨阿托伐他汀与记忆丧失之间的关系：基于真实世界药物警戒学和孟德尔随机化的综合分析。
Drugs R D. 2024 Jun;24(2):317-329. doi: 10.1007/s40268-024-00474-6. Epub 2024 Jul 4.
7
Inappropriate laboratory test utilization in outpatient tertiary care: Implications for value-based healthcare.门诊三级医疗中实验室检查的不恰当使用：对基于价值的医疗保健的影响。
Saudi Med J. 2024 Apr;45(4):356-361. doi: 10.15537/smj.2024.45.4.20230512.
8
Cardiovascular outcomes following hospitalisation for exacerbation of bronchiectasis: a territory-wide study.支气管扩张症恶化住院后的心血管结局：全岛范围研究。
BMJ Open Respir Res. 2024 Apr 18;11(1):e001804. doi: 10.1136/bmjresp-2023-001804.
9
Prevalence and management of dyslipidemia in primary care practices in Canada.加拿大初级保健实践中血脂异常的患病率和管理。
Can Fam Physician. 2024 Mar;70(3):187-196. doi: 10.46747/cfp.7003187.
10
Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study.低密度脂蛋白胆固醇（LDL-C）高于指南推荐阈值的动脉粥样硬化性心血管疾病患者复发性心血管事件的真实世界风险：一项回顾性观察研究。
Cardiol Ther. 2024 Mar;13(1):205-220. doi: 10.1007/s40119-024-00349-6. Epub 2024 Jan 29.

本文引用的文献

1
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.瑞舒伐他汀与血液透析患者的心血管事件
N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30.
2
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.瑞舒伐他汀起始治疗后C反应蛋白、低密度脂蛋白胆固醇降低及心血管事件发生率：JUPITER试验的前瞻性研究
Lancet. 2009 Apr 4;373(9670):1175-82. doi: 10.1016/S0140-6736(09)60447-5. Epub 2009 Mar 28.
3
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.不同脂肪、蛋白质和碳水化合物组成的减肥饮食的比较。
N Engl J Med. 2009 Feb 26;360(9):859-73. doi: 10.1056/NEJMoa0804748.
4
Metabolic syndrome associated with HIV and highly active antiretroviral therapy.与HIV及高效抗逆转录病毒治疗相关的代谢综合征
Curr Diab Rep. 2009 Feb;9(1):37-42. doi: 10.1007/s11892-009-0008-7.
5
Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl.低密度脂蛋白<70mg/dl的患者经皮冠状动脉介入治疗后高密度脂蛋白胆固醇与死亡率的关系。
Am J Cardiol. 2009 Feb 1;103(3):350-4. doi: 10.1016/j.amjcard.2008.09.087. Epub 2008 Nov 19.
6
National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.美国国家临床生物化学学会实验室医学实践指南：心血管疾病一级预防的新兴生物标志物
Clin Chem. 2009 Feb;55(2):378-84. doi: 10.1373/clinchem.2008.115899. Epub 2008 Dec 23.
7
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.残余风险降低倡议：呼吁采取行动降低血脂异常患者的残余血管风险。
Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K. doi: 10.1016/S0002-9149(08)01833-X.
8
Diagnostic performance of coronary angiography by 64-row CT.64排CT冠状动脉造影的诊断性能
N Engl J Med. 2008 Nov 27;359(22):2324-36. doi: 10.1056/NEJMoa0806576.
9
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
10
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.C反应蛋白和家族病史可改善总体心血管风险预测：男性的雷诺兹风险评分
Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251. doi: 10.1161/CIRCULATIONAHA.108.814251. Epub 2008 Nov 9.